IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Senti Biosciences Inc

CUSIP: 81726A100 | 48 institutional holders

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Beneficial Ownership — 13D / 13G

Full history →

5%+ stakes reported outside the quarterly cycle. A 13D is due within five business days of the event below, so these figures lead the holders table until the filer's next 13F catches up to them.

HolderShares% of ClassChangeEvent Datevs 13F
13D/ABayer HealthCare LLC6,142,84817.8%New 5%+ stakeMar 27, 2026No 13F filer matched
13D/ABayer HealthCare LLC6,142,848
17.8% of class · Mar 27, 2026

Institutional Holders — Q3 2025

8VC GP I, LLC253,755
0.5% of portfolio›$357.8K
StyleTurnoverLocationFiled
8VC GP I, LLC
253,755$357.8K0.5%N/AN/AAustin, TX2025-11-12
New 5%+ stake
No 13F filer matched